Your browser doesn't support javascript.
loading
A global analysis of One Health Networks and the proliferation of One Health collaborations.
Mwatondo, Athman; Rahman-Shepherd, Afifah; Hollmann, Lara; Chiossi, Scott; Maina, Josphat; Kurup, Karishma Krishna; Hassan, Osama Ahmed; Coates, Beatrice; Khan, Mishal; Spencer, Julia; Mutono, Nyamai; Thumbi, Samuel M; Muturi, Mathew; Mutunga, Mumbua; Arruda, Liã Bárbara; Akhbari, Melika; Ettehad, Dena; Ntoumi, Francine; Scott, Terence P; Nel, Louis H; Ellis-Iversen, Johanne; Sönksen, Ute Wolff; Onyango, Diana; Ismail, Zuleka; Simachew, Kebadu; Wolking, David; Kazwala, Rudovick; Sijali, Zikankuba; Bett, Bernard; Heymann, David; Kock, Richard; Zumla, Alimuddin; Dar, Osman.
Afiliação
  • Mwatondo A; Zoonotic Disease Unit, Ministry of Health, Nairobi, Kenya; International Livestock Research Institute, Nairobi, Kenya; Royal Institute of International Affairs, London, UK. Electronic address: amwatondo@yahoo.com.
  • Rahman-Shepherd A; London School of Hygiene & Tropical Medicine, London, UK; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore; Royal Institute of International Affairs, London, UK.
  • Hollmann L; Royal Institute of International Affairs, London, UK.
  • Chiossi S; Royal Institute of International Affairs, London, UK.
  • Maina J; Zoonotic Disease Unit, Ministry of Health, Nairobi, Kenya; International Livestock Research Institute, Nairobi, Kenya.
  • Kurup KK; Royal Institute of International Affairs, London, UK.
  • Hassan OA; Royal Institute of International Affairs, London, UK.
  • Coates B; Royal Institute of International Affairs, London, UK.
  • Khan M; London School of Hygiene & Tropical Medicine, London, UK; Department of Community Health Sciences and Department of Pathology, Aga Khan University, Karachi, Pakistan; Royal Institute of International Affairs, London, UK.
  • Spencer J; London School of Hygiene & Tropical Medicine, London, UK.
  • Mutono N; Paul G Allen School for Global Animal Health, Washington State University, Pullman, WA, USA; Center for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya.
  • Thumbi SM; Paul G Allen School for Global Animal Health, Washington State University, Pullman, WA, USA; Center for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK.
  • Muturi M; Zoonotic Disease Unit, Ministry of Agriculture, Livestock, and Fisheries, Nairobi, Kenya; International Livestock Research Institute, Nairobi, Kenya.
  • Mutunga M; Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya.
  • Arruda LB; Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK.
  • Akhbari M; Clinical Academic Training Office, University of Cambridge, Cambridge, UK.
  • Ettehad D; Academic Foundation Programme, Faculty of Medicine, Imperial College London, Imperial College Healthcare NHS Trust, London, UK.
  • Ntoumi F; Fondation Congolaise pour la Recherche Médicale, Brazzaville, Democratic Republic of the Congo; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
  • Scott TP; Global Alliance for Rabies Control, Pretoria, South Africa.
  • Nel LH; Department of Biochemistry, Genetics, and Microbiology, University of Pretoria, Pretoria, South Africa.
  • Ellis-Iversen J; The Danish Veterinary and Food Administration, Glostrup, Denmark.
  • Sönksen UW; National Centre for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
  • Onyango D; The One Health for Humans, Environment, Animals and Livelihoods Project, Addis Ababa, Ethiopia.
  • Ismail Z; The One Health for Humans, Environment, Animals and Livelihoods Project, Addis Ababa, Ethiopia.
  • Simachew K; The One Health for Humans, Environment, Animals and Livelihoods Project, Addis Ababa, Ethiopia.
  • Wolking D; One Health Institute, University of California, Davis, CA, USA.
  • Kazwala R; Department of Veterinary Medicine and Public Health, Sokoine University of Agriculture, Morogoro, Tanzania.
  • Sijali Z; Department of Veterinary Medicine and Public Health, Sokoine University of Agriculture, Morogoro, Tanzania.
  • Bett B; International Livestock Research Institute, Nairobi, Kenya.
  • Heymann D; Department of Infectious Disease Epidemiology, London, UK.
  • Kock R; Royal Veterinary College, University of London, London, UK.
  • Zumla A; Department of Infection, Division of Infection and Immunity, University College London, London, UK; National Institute for Health and Care Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
  • Dar O; Global Health Programme, Royal Institute of International Affairs, London, UK; Global Operations, UK Health Security Agency, London, UK.
Lancet ; 401(10376): 605-616, 2023 02 18.
Article em En | MEDLINE | ID: mdl-36682370
There has been a renewed focus on threats to the human-animal-environment interface as a result of the COVID-19 pandemic, and investments in One Health collaborations are expected to increase. Efforts to monitor the development of One Health Networks (OHNs) are essential to avoid duplication or misalignment of investments. This Series paper shows the global distribution of existing OHNs and assesses their collective characteristics to identify potential deficits in the ways OHNs have formed and to help increase the effectiveness of investments. We searched PubMed, Google, Google Scholar, and relevant conference websites for potential OHNs and identified 184 worldwide for further analysis. We developed four case studies to show important findings from our research and exemplify best practices in One Health operationalisation. Our findings show that, although more OHNs were formed in the past 10 years than in the preceding decade, investment in OHNs has not been equitably distributed; more OHNs are formed and headquartered in Europe than in any other region, and emerging infections and novel pathogens were the priority focus area for most OHNs, with fewer OHNs focusing on other important hazards and pressing threats to health security. We found substantial deficits in the OHNs collaboration model regarding the diversity of stakeholder and sector representation, which we argue impedes effective and equitable OHN formation and contributes to other imbalances in OHN distribution and priorities. These findings are supported by previous evidence that shows the skewed investment in One Health thus far. The increased attention to One Health after the COVID-19 pandemic is an opportunity to focus efforts and resources to areas that need them most. Analyses, such as this Series paper, should be used to establish databases and repositories of OHNs worldwide. Increased attention should then be given to understanding existing resource allocation and distribution patterns, establish more egalitarian networks that encompass the breadth of One Health issues, and serve communities most affected by emerging, re-emerging, or endemic threats at the human-animal-environment interface.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Saúde Única / COVID-19 Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Saúde Única / COVID-19 Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article